Mutations in BRCA2 (HR = 1.74), EPPK1 (HR = 1.59), and SPEN (HR = 2.02) were risk factors for patients with HCC, while MUC16 mutation (HR 0.32) was a protective factor. This evidence concerns the gene MUC16 and hepatocellular carcinoma.